medline.ch Respirationstrakt Neoplasie

	SMAD4 mRNA expression as a diagnostic biomarker in non-small cell lung cancer. Mol Biol Rep Babic T, Karanovic J, Stankovic T, Dragoj M, Nikolic A. PMID: 42631856 [PubMed - indexed for MEDLINE]
	Melatonin in lung cancer: integrating molecular mechanisms, tumor microenvironment regulation, apoptotic signaling, and therapeutic opportunities. Clin Transl Oncol Wu J, Kang H, Huang Y, Ruan L, Nan F, Sabihi SS. PMID: 42631834 [PubMed - as supplied by publisher]
	Association of AI-Assisted Training with Learning Outcomes in Lung Cancer Puncture Ablation: A Retrospective Before-and-After Study. Adv Med Educ Pract Ren Y, Chen C, Luo C, Kan X, Zhou G, Zheng C. PMID: 42631249 [PubMed]
	Should we optimise or revise the management of initially unresectable stage III non-small cell lung cancer: rethinking consolidation therapy. J Natl Cancer Cent Tafenzi HA, Essadi I, Belbaraka R. PMID: 42630841 [PubMed]
	Epidemiological characteristics and risk factors of lung cancer in a population with incidental pulmonary nodules in China: a prospective multicenter study of 10,560 cases. J Natl Cancer Cent Liang W, Zhou Y, Hu C, Xiao W, Zhang J, Li M, Wang W, Ye X, Zhang X, Chang N, Yun C, Sun D, Zhang Y, Qin Z, Wang W, Zhang Y, Zhang X, Xiang Y, Qu J, Zhang W, Sun L, Hu Y, Xu J, Wu D, Zhao J, Zhang X, Bao H, Liu X, Guo Y, Li Z, Zhang Q, Zhu W, Yang L, Dang X, Han B, Tong Z, Wang F, Liu L, Peng M, Wu S, Zeng L, Teng L, Qiu X, Wang B, Tao J, Yang M, Zhao J, Chen SS, Fan J, Li W, Liu D, He J, Zhong N. PMID: 42630839 [PubMed]
	The mechano-immunological barrier in fibrosis-associated lung cancer: targeting matrix stiffness and the Piezo1 axis for microenvironment normalization. Front Pharmacol Guo L, Wang J, Ni B, Jiang J. PMID: 42630570 [PubMed]
	Lorlatinib-specific outcomes by timing of lorlatinib initiation in advanced ALK-positive non-small cell lung cancer: A retrospective cohort study. Ther Adv Med Oncol Song R, Li X, Han N, Liu D, Xu Y. PMID: 42630380 [PubMed]
	Pulmonary adenofibroma: MSCT and clinicopathological analysis of three case reports and a literature review. Medicine (Baltimore) Chen W, Liu K, Zhao Y, Liu CC, Cao MY, Wang XJ. PMID: 42629758 [PubMed - indexed for MEDLINE]
	Efficacy of a new surgical indicator for lung cancer with interstitial lung disease based on the gender-age-physiology staging system. Int J Clin Oncol Imamura Y, Nakanishi K, Huang H, Sugihara M, Ryo T, Ichikawa Y, Masuda T, Takenaka H, Kawasumi Y, Watanabe H, Kadomatsu Y, Ueno H, Kato T, Nakamura S, Mizuno T, Chen-Yoshikawa TF. PMID: 42629538 [PubMed - as supplied by publisher]
	A single-chip, dual-gain color-NIR camera for fluorescence-guided lung and breast cancer surgery. Light Sci Appl Zhu Z, Hajek B, Jin Y, Stojanovski S, Jankulovska A, Angjushev D, Djikovski I, Jakupi N, Colanceski R, Ferati I, Antevski B, Vela I, Despotovski D, Tolevska Dimitrovska N, Bogdanovska Todorovska M, Kondov G, Kondov B, Nie S, Singhal S, Gruev V. PMID: 42629355 [PubMed]
	Paediatric tracheal carcinoid with carinal involvement and nodal metastasis: challenging airway reconstruction with oncological clearance. BMJ Case Rep Kapoor R, Kumar S, Kumar N, B N N. PMID: 42628989 [PubMed - indexed for MEDLINE]
	Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study. Ann Oncol Wakelee H, Spicer JD, Gao S, Liberman M, Tsuboi M, Kato T, Chen KN, Dooms C, Majem M, Martinengo GL, Bylicki O, Rodríguez-Abreu D, Halmos B, Jones DR, Chaft JE, Reck M, Jensen E, Keller SM, Samkari A, Garassino MC. PMID: 42628840 [PubMed - as supplied by publisher]
	Genomic Profiling, Risk Stratification, and Post-Transformation Treatment Outcomes in Patients with Transformed Small-Cell Lung Cancer: A Multicenter Analysis. Lung Cancer Gao R, Li Z, Huang J, Zhao J, Wang Y, Guo Q, Deng G, Bai H, Yang X, Duan J, Wang Z, Wang Y, Wang J, Xu J, Wan R, Sun B, Fei K, Ma Z, Zhong J, Wang J. PMID: 42628300 [PubMed - as supplied by publisher]
	Postprocedural pain after microwave ablation versus cryoablation for pulmonary tumors: A retrospective comparative study. Cryobiology Liu HY, Lee WJ, Chen HM, Wu CF, Huang PM, Lee JM, Huang YS, Chang YC, Ko WC. PMID: 42628235 [PubMed - as supplied by publisher]
	The application of excess hazard models for plausible long-term extrapolation in cost-effectiveness: a re-evaluation of immunotherapy in advanced non-small cell lung cancer using the KEYNOTE-024 trial. Eur J Health Econ Kim K, Sweeting M, Wilking N, Jönsson L. PMID: 42627465 [PubMed - as supplied by publisher]
	Lung Cancer Screening Access and Cancer Stage at Diagnosis Among American Indian and White Patients. J Rural Health Jackson BE, Uhrin M, Wheeler SB, Baggett CD, Spees LP, Begay JA, Bell RA, Emerson MA. PMID: 42627130 [PubMed - indexed for MEDLINE]
	Efficacy and safety of almonertinib as adjuvant therapy in stage II-IIIA EGFR-mutant non-small cell lung cancer: a retrospective study. Front Med (Lausanne) Cao T, Chen L, Li Y, Wu S, Liu Y, Tian W, Zhang Y, An Y, Wang M, Lu Z, Wang Q. PMID: 42625890 [PubMed]
	Implementation of a lung cancer screening program at an urban safety-net hospital: enabling solutions via stakeholder engagement. Front Public Health Kuperberg SJ, Mercado J. PMID: 42625749 [PubMed - indexed for MEDLINE]
	The relationship between sarcopenia detected in newly diagnosed lung cancer patients and serum levels of IL6, IGF-1 and myostatin. Front Aging Süzer K, Oflazoglu U, Demir L, Unal S, Guc ZG, Yildiz Y, Karalar FO, Kucukzeybek Y, Alacacioglu A. PMID: 42625663 [PubMed]
	An integrated multimodal model for early prediction of high-risk recurrence phenotype indicative of poor disease-free survival in stage IA NSCLC: a multicenter study. Front Immunol Lai L, Wang Y, Jiang J, Yang D, Wu J, Xie L, Wu J, Mao R, Zhang D, Wang X, Ming W, Tu J. PMID: 42625643 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 162464

Seite 1 von 8124



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung